Cardio Diagnostics Holdings CDIO
NASDAQ CDIO
$1.64 -0.07 (-4.09%)
As of: Oct 19, 2026 · 3:15 PM EDT

Cardio Diagnostics Holdings (CDIO) Restructuring Costs (2022)

Updated

Cardio Diagnostics Holdings (CDIO) recorded Restructuring Costs of $112,534 in FY2022.

Analysis

Cardio Diagnostics Holdings (CDIO) Restructuring Costs (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 251.93 Bn 230.96 Bn 4.88 Bn
2 Abbott Laboratories 181.29 Bn 151.72 Bn 7.27 Bn
3 Danaher 158.18 Bn 141.99 Bn 3.61 Bn
4 Intuitive Surgical 153.47 Bn 132.89 Bn 1.96 Bn
5 Medtronic 118.97 Bn 84.22 Bn 6.34 Bn
6 Stryker 114.72 Bn 100.84 Bn 4.50 Bn
7 Boston Scientific 66.18 Bn 60.95 Bn 3.85 Bn
8 Becton Dickinson 52.49 Bn 49.64 Bn 2.32 Bn
9 Edwards Lifesciences 50.32 Bn 34.33 Bn 1.35 Bn
10 Cardio Diagnostics Holdings 4.85 Mn -19.28 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 55,034.00
Mar 31, 2022 57,500.00
API Access

Cardio Diagnostics Holdings Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CDIO&period=max&api_key=YOUR_API_KEY